Corrigendum: Cardiac tamponade, a rare complication of gastric cardia cancer resection after neoadjuvant chemotherapy combined with immunotherapy: a case report and literature review

Wei Du,Hemei Wang,Junmei Shen,Xi Qiao,Jifang Yao,Chao Li

DOI: https://doi.org/10.3389/fonc.2023.1355675

IF: 4.7

2024-01-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1189500.].

oncology

What problem does this paper attempt to address?

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Lijun Du,Jinhua Shen,John J. Kim,Yunxian Yu,Lu Ma,Ning Dai

DOI: https://doi.org/10.1038/srep46121

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 34305; published online: 06 October 2016; updated: 07 April 2017 Affiliation 1 was incorrectly listed as ‘Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang province 310016, China’ in the original version of the Article.
Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Corrigendum]

Pei Wu,Pengliang Wang,Bin Ma,Songcheng Yin,Yuen Tan,Wenbin Hou,Zhenning Wang,Huimian Xu,Zhi Zhu

DOI: https://doi.org/10.2147/cmar.s455833

2024-01-01

Cancer Management and Research

Abstract:[This corrects the article DOI: 10.2147/CMAR.S179368.].

oncology
Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Qiao Ke,Fuli Xin,Huipeng Fang,Yongyi Zeng,Lei Wang,Jingfeng Liu

DOI: https://doi.org/10.3389/fimmu.2022.952446

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature

Mef Nilbert,Jakob Eberhard,Jenny Engdahl Severin,Marcus Edelhamre,Filip Torle,Dejan Korkocic,Fredrik Jörgren

DOI: https://doi.org/10.2340/1651-226x.2024.40158

IF: 4.311

2024-02-29

Acta Oncologica

Abstract:Corrigendum for article: DOI: 10.1080/0284186X.2023.2281005

oncology
Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Linlin Xiao,Yvonne M. Mowery,Brian G. Czito,Yajing Wu,Guangbin Gao,Chang Zhai,Jianing Wang,Jun Wang

DOI: https://doi.org/10.3389/fonc.2022.827810

IF: 4.7

2022-02-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.652509.].

oncology
Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Yuan Li,Lin Wang,Jianning Zhang,Hui Han,Han Liu,Chaoyang Li,Haipeng Guo,Yuguo Chen,Xiaomei Chen

DOI: https://doi.org/10.3389/fcvm.2021.784904

IF: 3.6

2021-10-29

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.645867.].

cardiac & cardiovascular systems
Corrigendum to "the Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis".

Qiufang Liu,Chen Wang,Panli Li,Jianjun Liu,Gang Huang,Shaoli Song

DOI: https://doi.org/10.1155/2016/1235429

2016-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2016/3746232.].
Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Zhiwen Fu,Jinmei Liu,Shijun Li,Chen Shi,Yu Zhang

DOI: https://doi.org/10.1016/j.eclinm.2023.101908

IF: 15.1

2023-01-01

EClinicalMedicine

Abstract:[This corrects the article DOI: 10.1016/j.eclinm.2023.101904.][This corrects the article DOI: 10.1016/j.eclinm.2022.101795.].
Corrigendum to "re: Pathologic Complete Responses, Long-Term Outcomes, and Recurrence Patterns in HER2-low Vs. HER2-zero Breast Cancer after Neoadjuvant Chemotherapy: Several Issues about HER2 Expression and Neoadjuvant Chemotherapy in Breast Cancer" [eur J Cancer 180 (2023) 184-185].

Fan Yang,Guanmo Liu,Feng Mao,Yong-Chang Zheng

DOI: https://doi.org/10.1016/j.ejca.2024.113559

2024-01-01

Abstract:The authors regret that an error was made in the detail for affiliation c. The correct affiliation is: Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. The authors would like to apologise for any inconvenience caused. Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancerEuropean Journal of CancerVol. 180PreviewWe followed with interest the report by Sora Kang et al. that pathological complete response (pCR) rate and disease-free survival (DFS) in patients with HER2-low as well as HER2-0 breast cancers who have undergone neoadjuvant chemotherapy [1]. There are many complex factors influencing condition of response and survival of breast cancer after neoadjuvant therapy by the changes of HER2 and hormone receptor (HR) status. We appreciated the authors' work in comparing the prognosis of patients with breast cancer after neoadjuvant chemotherapy in different HER2 status and providing new therapeutic ideas. Full-Text PDF
Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Mianmian Liao,Caiwei Wang,Bowen Yang,Danping Huang,Yifeng Zheng,Shengqi Wang,Xuan Wang,Juping Zhang,Chunbian Tang,Zheng Xu,Yu He,Ruolin Huang,Fengxue Zhang,Zhiyu Wang,Neng Wang

DOI: https://doi.org/10.3389/fphar.2022.809565

IF: 5.6

2022-02-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.659297.].

pharmacology & pharmacy
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Acute Abdomen after Vertebroplasty-a Rare Complication.

Xiao-Ming Zhao,Xiao-Xiao Lou,An-Fa Chen,Yin-Gang Zhang

DOI: https://doi.org/10.3389/fsurg.2024.1509452

IF: 1.8

2024-01-01

Frontiers in Surgery

Abstract:[This corrects the article DOI: 10.3389/fsurg.2022.1048107.].
Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Xinhua Chen,Huimin Zhang,Minghao Wang,Hao Liu,Yanfeng Hu,Tian Lin,Hao Chen,Mingli Zhao,Tao Chen,Guoxin Li,Jiang Yu,Liying Zhao

DOI: https://doi.org/10.3389/fimmu.2023.1235273

IF: 7.3

2023-06-15

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783695.].

immunology
Corrigendum: Anticancer applications of phytochemicals in gastric cancer: effects and molecular mechanism

Zhaofeng Liang,Yumeng Xu,Yue Zhang,Xinyi Zhang,Jiajia Song,Hui Qian,Jianhua Jin

DOI: https://doi.org/10.3389/fphar.2024.1405513

2024-08-19

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1078090.].
Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Shaoyan Xu,Chenlu Hu,Zedong Jiang,Guogang Li,Bo Zhou,Zhenzhen Gao,Weilin Wang,Sheng Yan

DOI: https://doi.org/10.3389/fonc.2023.1251636

IF: 4.7

2023-08-11

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1214451.].

oncology
Erratum: [Corrigendum] Survival outcomes in patients with T3‑4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy.

Jian Zhou,Yu Heng,Yue Yang,Xiaoke Zhu,Liang Zhou,Hongli Gong,Chengzhi Xu,Lei Tao

DOI: https://doi.org/10.3892/ol.2024.14456

2024-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2022.13554.].
Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Xueyao Yang,Jinfan Tian,Lijun Zhang,Wei Dong,Hongzhi Mi,Jianan Li,Jiahui Li,Ye Han,Huijuan Zuo,Jing An,Yi He,Xiantao Song

DOI: https://doi.org/10.3389/fcvm.2022.877972

IF: 3.6

2022-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.754826.].
Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Xiaozhong Liao,Ying Gao,Jiahui Liu,Lan-Ting Tao,Dongmei Wang,Dan Xie,Sui‐Lin Mo

DOI: https://doi.org/10.3389/fonc.2021.670798

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.01756/full.].
Primary Neuroendocrine Breast Carcinomas: a Retrospective Analysis and Review of Literature [Corrigendum]

Xin Yang,Youde Cao,Chen,Lin Liu,Cheng Wang,Shengchun Liu

DOI: https://doi.org/10.2147/ott.s135552

IF: 4

2017-01-01

OncoTargets and Therapy

Abstract:[This corrects the article on p. 397 in vol. 10, PMID: 28176908.].

Corrigendum: Cardiac tamponade, a rare complication of gastric cardia cancer resection after neoadjuvant chemotherapy combined with immunotherapy: a case report and literature review

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Corrigendum]

Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Corrigendum to "the Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis".

Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Corrigendum to "re: Pathologic Complete Responses, Long-Term Outcomes, and Recurrence Patterns in HER2-low Vs. HER2-zero Breast Cancer after Neoadjuvant Chemotherapy: Several Issues about HER2 Expression and Neoadjuvant Chemotherapy in Breast Cancer" [eur J Cancer 180 (2023) 184-185].

Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Acute Abdomen after Vertebroplasty-a Rare Complication.

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Corrigendum: Anticancer applications of phytochemicals in gastric cancer: effects and molecular mechanism

Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Erratum: [Corrigendum] Survival outcomes in patients with T3‑4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy.

Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Primary Neuroendocrine Breast Carcinomas: a Retrospective Analysis and Review of Literature [Corrigendum]